| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.44 | 2e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.37 | 5e-09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.35 | 6e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 4e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.33 | 7e-07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |